Phenylpyazoleanilides as Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 2: Discovery of a New Drug Candidate, Y-320

Author(s): Hiroyuki Ushio, Seigo Ishibuchi, Kunitomo Adachi, Kouichi Oshita, Kenji Chiba

Journal Name: Letters in Drug Design & Discovery

Volume 5 , Issue 4 , 2008

Become EABM
Become Reviewer


Through the optimization of the active metabolite 2 of the piperidine derivative 1, we discovered a potent new drug candidate for the treatment of RA, Y-320 that inhibits T cell activation induced by IL-15 and shows a therapeutic effect on collagen-induced arthritis in DBA/1J mice. Design and structure-activity relationships are described.

Keywords: Y-320, IL-15, Phenylpyrazoleanilide, RA, CIA

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [292 - 296]
Pages: 5
DOI: 10.2174/157018008784619861

Article Metrics

PDF: 41